Home Dossiers China approves inactivated COVID-19 vaccines for clinical trials

China approves inactivated COVID-19 vaccines for clinical trials

Xinhua

The two vaccine candidates are developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group (Sinopharm) and Sinovac Research and Development Co., Ltd, a company based in Beijing. Clinical trials of the two vaccines have started.

Contact Us

Generalist media, focusing on the relationship between Portuguese-speaking countries and China.

Plataforma Studio

Newsletter

Subscribe Plataforma Newsletter to keep up with everything!